Use of the 4Kscore test to predict the risk of aggressive prostate cancer prior to prostate biopsy: Overall cost savings and improved quality of care to the us healthcare system.

Voigt, Jeffrey D; Dong, Yan; Linder, Vincent; Zappala, Stephen

Voigt, Jeffrey D; Dong, Yan; Linder, Vincent; Zappala, Stephen.

Afiliação

Voigt JD; Medical Device Consultants of Ridgewood, LLCRidgewood, NJ.
Dong Y; OPKO DiagnosticsWoburn, MA.
Linder V; OPKO DiagnosticsWoburn, MA.
Zappala S; Medical Device Consultants of Ridgewood, LLCRidgewood, NJ.

Rev Urol ; 19(1): 1-10, 2017.

Article em En | MEDLINE | ID: mdl-28522924

Palavras-chave

4Kscore Test; Cost savings; PSA screening; Prostate biopsy; Prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspecto: Implementation_research Idioma: En Revista: Rev Urol Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google